Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study
Stefano Ciardullo, Federico Rea, Laura Savaré, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. e2671-e2679
Open Access | Times Cited: 24

Showing 24 citing articles:

Individualized prevention of proton pump inhibitor related adverse events by risk stratification
Bin Xia, Qiangsheng He, Fang Gao Smith, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Impact of anti-peptic ulcer disease medications on type 2 diabetes mellitus risk in patients with PUD: a population-based retrospective cohort study
Yi‐Jen Fang, Hui-Hsia Hsieh, Cheng‐Li Lin, et al.
Therapeutic Advances in Endocrinology and Metabolism (2025) Vol. 16
Open Access
Association and Mechanisms of Proton Pump Inhibitors Use with Type-2 Diabetes Mellitus Incidence in Adults: A Systemic Review and Meta-Analysis
Santenna Chenchula, Phulen Sharma, Mohan Krishna Ghanta, et al.
Current Diabetes Reviews (2024) Vol. 20, Iss. 10
Closed Access | Times Cited: 4
Time Trends in Liver-Related Mortality in People With and Without Diabetes: Results From a Population-Based Study
Stefano Ciardullo, Gabriella Morabito, Federico Rea, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 10, pp. 2513-2519
Open Access | Times Cited: 4
Proton pump inhibitor use is associated with increased liver steatosis
Hongsheng Yu, Mingkai Li, Bilan Yang, et al.
Biomedical Reports (2024) Vol. 21, Iss. 2
Open Access | Times Cited: 2
Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients With Type 2 Diabetes
Tingting Geng, Jun‐Xiang Chen, Yanfeng Zhou, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 6, pp. e216-e222
Closed Access | Times Cited: 9
Exposure to proton pump inhibitors and risk of diabetes: A systematic review and meta-analysis
Yun-Ran Guo, Xinming Liu, Guixia Wang
World Journal of Diabetes (2023) Vol. 14, Iss. 2, pp. 120-129
Open Access | Times Cited: 4
Drug-induced hyperglycemia and diabetes
Marie-Anne Heurtebize, Jean‐Luc Faillie
Therapies (2023) Vol. 79, Iss. 2, pp. 221-238
Open Access | Times Cited: 4
Self-controlled Case Series Study for Acute Kidney Injury after Starting Proton Pump Inhibitors or Potassium-Competitive Acid Blocker in Patients with Cancer Using a Large Claims Database
Kosuke Suzuki, Ayako Watanabe, Yoshihiro Kiryu, et al.
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 2, pp. 518-526
Open Access | Times Cited: 1
Alterations in gut microbiota and bile acids by proton‐pump inhibitor use and possible mediating effects on elevated glucose levels and insulin resistance
Qiangsheng He, Bin Xia, Man Sik Yang, et al.
The FASEB Journal (2024) Vol. 38, Iss. 6
Closed Access | Times Cited: 1
Widening spectrum of adverse effects caused by long-term use of proton pump inhibitors: A comprehensive review of literature
AS Mir, Zahoor A. Wani, Ajmal R. Baht, et al.
LabMed discovery. (2024), pp. 100027-100027
Open Access | Times Cited: 1
Evidence for proton-pump inhibitor (PPI)-associated dysbiosis in metabolically unhealthy obesity
Melissa A. Burmeister, Tara E. Smith, Timothy K. Fincher, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3
From contact coverage to effective coverage of community care for patients with severe mental disorders: A real-world investigation from Italy
Giovanni Corrao, Matteo Monzio Compagnoni, Angelo Barbato, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 5
consequences of long-term therapy with proton pump inhibitors
Zuzanna Drygała, Julia Wyrwał, Martyna Krasuska, et al.
Journal of Education Health and Sport (2024) Vol. 53, pp. 44-59
Open Access
PPI use associated with decreased new-onset diabetes risk in Korean NHIS-HEALS cohort
Ye-Seul Kim, Jeong Sook Kim, Hyo‐Sun You, et al.
Research Square (Research Square) (2024)
Open Access
Efficacy and safety of proton pump inhibitors on cardiovascular events and inflammatory factors in patients with upper gastrointestinal bleeding undergoing dual antiplatelet therapy
Shuting Yang, L P Shi
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1999-2006
Closed Access
Side effects of proton pump inhibitors with long-term use: focus on the urinary system
Д. И. Трухан, И. А. Викторова
Medical alphabet (2024), Iss. 5, pp. 36-42
Closed Access
Effects of Proton Pump Inhibitors on Cardiovascular Events and Inflammatory Factors in Patients With Upper Gastrointestinal Bleeding Undergoing Dual Antiplatelet Therapy
Farhan Aslam, Afaq Naeem, Emad Munir, et al.
Cureus (2024)
Open Access
Cardiovascular risk with long-term use of proton pump inhibitors: myth or reality. A review
Д. И. Трухан, С. Н. Филимонов
Consilium Medicum (2024) Vol. 26, Iss. 1, pp. 55-60
Open Access
Side effects of gastrointestinal drugs
Dianne May, Devin L. Lavender, Emily Hightower
Side effects of drugs annual (2023), pp. 365-381
Closed Access | Times Cited: 1
“Chronic Exposure to Proton Pump Inhibitor use and Diabetes Mellitus Incidence. A Systemic Review and Meta-Analysis “
Santenna Chenchula, PHULEN Sharma, Mohan Krishna Ghanta, et al.
Research Square (Research Square) (2023)
Open Access
Do the benefits outweigh the risks? Potential dangers associated with long-term therapy of proton pump inhibitors
Izabela WOLANIN, Bartłomiej ZIELONKA, Barbara Dengler, et al.
Journal of Education Health and Sport (2023) Vol. 26, Iss. 1, pp. 63-80
Open Access
Proton Pump Inhibitors Use is Associated with Increased Liver Steatosis: A Nationally Representative Study
Hongsheng Yu, Mingkai Li, Bilan Yang, et al.
Research Square (Research Square) (2023)
Open Access
Long-term use of proton pump inhibitors and risk of diabetes mellitus: the totality of the evidence does not support a change in practice
Giovanna Liuzzo, Carlo Patrono
European Heart Journal (2022) Vol. 43, Iss. 40, pp. 3995-3996
Closed Access
Page 1

Scroll to top